{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T09:30:14Z","timestamp":1770543014834,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s40123-025-01269-x","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T02:25:08Z","timestamp":1763173508000},"page":"323-337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishing Expert Consensus on a Unified Decision Framework for Retina Patient Care"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2338-8143","authenticated-orcid":false,"given":"Javier","family":"Zarranz-Ventura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6543-3400","authenticated-orcid":false,"given":"Aude","family":"Ambresin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7555-1585","authenticated-orcid":false,"given":"Andrew","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-4771","authenticated-orcid":false,"given":"Christiana","family":"Dinah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7850-8515","authenticated-orcid":false,"given":"Nancy M.","family":"Holekamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5599-1583","authenticated-orcid":false,"given":"Jorge","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-557X","authenticated-orcid":false,"given":"Insaf","family":"Saffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5859-8162","authenticated-orcid":false,"given":"Rishi P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"1269_CR1","doi-asserted-by":"publisher","first-page":"E106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:E106\u201316.","journal-title":"Lancet Glob Health"},{"key":"1269_CR2","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"Z Ling Teo","year":"2021","unstructured":"Ling Teo Z, Tham Y-C, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology. 2021;128:1580\u201391.","journal-title":"Ophthalmology"},{"key":"1269_CR3","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.010427","volume":"9","author":"P Song","year":"2019","unstructured":"Song P, Xu Y, Zha M, Zhang Y, Rudan I. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors. J Glob Health. 2019;9:010427.","journal-title":"J Glob Health"},{"key":"1269_CR4","unstructured":"National Institute for Health and Care Excellence (NICE). Diabetic retinopathy: management and monitoring. NICE guideline (NG242). 2024. https:\/\/www.nice.org.uk\/guidance\/ng242. Accessed August 2025."},{"key":"1269_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000502041","volume":"242","author":"U Schmidt-Erfurth","year":"2019","unstructured":"Schmidt-Erfurth U, Garcia-Arumi J, Gerendas BS, et al. Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2019;242:123\u201362.","journal-title":"Ophthalmologica"},{"key":"1269_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000458539","volume":"237","author":"U Schmidt-Erfurth","year":"2017","unstructured":"Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, et al. Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica. 2017;237:185\u2013222.","journal-title":"Ophthalmologica"},{"key":"1269_CR7","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","volume":"98","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U, Chong V, Loewenstein A, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014;98:1144\u201367.","journal-title":"Br J Ophthalmol"},{"key":"1269_CR8","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","volume":"125","author":"TY Wong","year":"2018","unstructured":"Wong TY, Sun J, Kawasaki R, et al. Guidelines on diabetic eye care: The International Council of Ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018;125:1608\u201322.","journal-title":"Ophthalmology"},{"key":"1269_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s40123-024-01060-4","volume":"14","author":"F Ziemssen","year":"2025","unstructured":"Ziemssen F, Sylvanowicz M, Amoaku WM, et al. Improving clinical management of diabetic macular edema: insights from a global survey of patients, healthcare providers, and clinic staff. Ophthalmol Ther. 2025;14:229\u201346.","journal-title":"Ophthalmol Ther"},{"key":"1269_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.survophthal.2023.09.001","volume":"69","author":"A Choi","year":"2024","unstructured":"Choi A, Nawash BS, Du K, Ong J, Chhablani J. Barriers to care in neovascular age-related macular degeneration: current understanding, developments, and future directions. Surv Ophthalmol. 2024;69:160\u20134.","journal-title":"Surv Ophthalmol"},{"key":"1269_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.15537\/smj.2021.2.25623","volume":"42","author":"AS AlQahtani","year":"2021","unstructured":"AlQahtani AS, Hazzazi MA, Waheeb SA, et al. Saudi Arabia guidelines for diabetic macular edema: a consensus of the Saudi Retina Group. Saudi Med J. 2021;42:131\u201345.","journal-title":"Saudi Med J"},{"key":"1269_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-07467-8","volume":"22","author":"C Willmington","year":"2022","unstructured":"Willmington C, Belardi P, Murante AM, Vainieri M. The contribution of benchmarking to quality improvement in healthcare. A systematic literature review. BMC Health Serv Res. 2022;22:139.","journal-title":"BMC Health Serv Res"},{"key":"1269_CR13","doi-asserted-by":"publisher","first-page":"8777","DOI":"10.1073\/pnas.1601827113","volume":"113","author":"RHJM Kurvers","year":"2016","unstructured":"Kurvers RHJM, Herzog SM, Hertwig R, et al. Boosting medical diagnostics by pooling independent judgments. Proc Natl Acad Sci USA. 2016;113:8777\u201382.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1269_CR14","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1126\/science.1193147","volume":"330","author":"AW Woolley","year":"2010","unstructured":"Woolley AW, Chabris CF, Pentland A, Hashmi N, Malone TW. Evidence for a collective intelligence factor in the performance of human groups. Science. 2010;330:686\u20138.","journal-title":"Science"},{"key":"1269_CR15","unstructured":"The Ophthalmology Network. A new Ophthalmology Network is in sight. 2024. https:\/\/ophthalmology-network.org\/. Accessed April 2025."},{"key":"1269_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004326","volume":"21","author":"WT Gattrell","year":"2024","unstructured":"Gattrell WT, Logullo P, van Zuuren EJ, et al. ACCORD (ACcurate COnsensus Reporting Document): a reporting guideline for consensus methods in biomedicine developed via a modified Delphi. PLoS Med. 2024;21:e1004326.","journal-title":"PLoS Med"},{"key":"1269_CR17","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","volume":"67","author":"IR Diamond","year":"2014","unstructured":"Diamond IR, Grant RC, Feldman BM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67:401\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1269_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198979","volume":"14","author":"MMPN Piyasena","year":"2019","unstructured":"Piyasena MMPN, Murthy GVS, Yip JLY, et al. Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings. PLoS ONE. 2019;14:e0198979.","journal-title":"PLoS ONE"},{"key":"1269_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40123-024-01061-3","volume":"14","author":"A Loewenstein","year":"2025","unstructured":"Loewenstein A, Sylvanowicz M, Amoaku WM, et al. Global insights from patients, providers, and staff on challenges and solutions in managing neovascular age-related macular degeneration. Ophthalmol Ther. 2025;14:211\u201328.","journal-title":"Ophthalmol Ther"},{"key":"1269_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41433-020-0961-6","volume":"34","author":"WM Amoaku","year":"2020","unstructured":"Amoaku WM, Ghanchi F, Bailey C, et al. Diabetic retinopathy and diabetic macular oedema pathways and management: UK consensus working group. Eye. 2020;34:1\u201351.","journal-title":"Eye"},{"key":"1269_CR21","unstructured":"National Institute for Health and Care Excellence (NICE). Macular degeneration\u2014age-related: what is the prognosis? 2022. https:\/\/cks.nice.org.uk\/topics\/macular-degeneration-age-related\/background-information\/prognosis\/. Accessed August 2025."},{"key":"1269_CR22","unstructured":"National Institute for Health and Care Excellence. Age-related macular degeneration. NICE guideline (NG82). 2018. www.nice.org.uk\/guidance\/ng82. Accessed August 2025."},{"key":"1269_CR23","unstructured":"The Royal College of Ophthalmologists. Retinal vein occlusion (RVO). 2022. https:\/\/www.rcophth.ac.uk\/wp-content\/uploads\/2015\/07\/Retinal-Vein-Occlusion-Guidelines-2022.pdf. Accessed August 2025."},{"key":"1269_CR24","unstructured":"The Royal Australian and New Zealand College of Ophthalmologists. RANZCO screening and referral pathway for diabetic retinopathy (including diabetic maculopathy). https:\/\/ranzco.edu\/wp-content\/uploads\/2020\/08\/RANZCO-Screening-and-Referral-Pathway-for-Diabetic-Retinopathy_2022.pdf. Accessed August 2025."},{"issue":"S1","key":"1269_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41433-018-0300-3","volume":"33","author":"RP Gale","year":"2019","unstructured":"Gale RP, Mahmood S, Devonport H, et al. Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye service. Eye (Lond). 2019;33(S1):1\u201321.","journal-title":"Eye (Lond)"},{"key":"1269_CR26","unstructured":"Gruszka-Goh MH, Mckibbin M, Burdon M. National Ophthalmology Database Audit. The third report of age-related macular degeneration audit (AMD). Patients starting treatment for neovascular AMD in the 2022 NHS year (01 April 2022 to 31 March 2023). https:\/\/live-nod-audit.pantheonsite.io\/sites\/default\/files\/2025-03\/NOD%20Audit%20Full%20Annual%20Report%202025_Final%20%281%29.pdf. Accessed August 2025."},{"key":"1269_CR27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12886-021-02181-1","volume":"21","author":"L Touma-Falci","year":"2021","unstructured":"Touma-Falci L, Moreira-Neto CA, Taleb AC, et al. Age-related macular degeneration and resource utilization in the Brazilian public healthcare system: a real-world retrospective study. BMC Ophthalmol. 2021;21:430.","journal-title":"BMC Ophthalmol"},{"key":"1269_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101095","volume":"4","author":"Z Li","year":"2023","unstructured":"Li Z, Wang L, Wu X, et al. Artificial intelligence in ophthalmology: the path to the real-world clinic. Cell Rep Med. 2023;4:101095.","journal-title":"Cell Rep Med"},{"key":"1269_CR29","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/ICU.0000000000000979","volume":"34","author":"YB Chou","year":"2023","unstructured":"Chou YB, Kale AU, Lanzetta P, et al. Current status and practical considerations of artificial intelligence use in screening and diagnosing retinal diseases: Vision Academy retinal expert consensus. Curr Opin Ophthalmol. 2023;34:403\u201313.","journal-title":"Curr Opin Ophthalmol"},{"key":"1269_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/eye.2017.1","volume":"31","author":"B Foot","year":"2017","unstructured":"Foot B, MacEwen C. Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome. Eye (Lond). 2017;31:771\u20135.","journal-title":"Eye (Lond)"},{"key":"1269_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-023-00502-8","volume":"9","author":"J Than","year":"2023","unstructured":"Than J, Sim PY, Muttuvelu D, et al. Teleophthalmology and retina: a review of current tools, pathways and services. Int J Retina Vitreous. 2023;9:76.","journal-title":"Int J Retina Vitreous"},{"key":"1269_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055845","volume":"12","author":"JED Han","year":"2022","unstructured":"Han JED, Liu X, Bunce C, et al. Teleophthalmology-enabled and artificial intelligence-ready referral pathway for community optometry referrals of retinal disease (HERMES): a cluster randomised superiority trial with a linked diagnostic accuracy study\u2014HERMES study report 1\u2014study protocol. BMJ Open. 2022;12:e055845.","journal-title":"BMJ Open"},{"key":"1269_CR33","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41433-022-02228-7","volume":"37","author":"JM Dewing","year":"2022","unstructured":"Dewing JM, Lotery AJ, Ratnayaka JA. The disparity between funding for eye research vs. the high cost of sight-loss in the UK. Eye (Lond). 2022;37:584\u20136.","journal-title":"Eye (Lond)"},{"key":"1269_CR34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/02646196211032694","volume":"41","author":"SL Young","year":"2021","unstructured":"Young SL, Ng N, Yap NJ, Hussain Z, Cackett PD. A novel multidisciplinary approach to the management of end-stage macular disease. Br J Vis Impair. 2021;41:432\u20138.","journal-title":"Br J Vis Impair"},{"key":"1269_CR35","unstructured":"National Institute for Health and Care Excellence (NICE). Glossary. https:\/\/www.nice.org.uk\/glossary?letter=c#:~:text=Clinical%20audit,level%20of%20quality%20is%20achieved. Accessed August 2025."},{"key":"1269_CR36","unstructured":"The Royal College of Ophthalmologists. Audit and data. https:\/\/www.rcophth.ac.uk\/standards-and-guidance\/audit-and-data\/. Accessed August 2025."},{"key":"1269_CR37","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1038\/s41433-024-03322-8","volume":"38","author":"M Puzo","year":"2024","unstructured":"Puzo M, Calvo-Perez P, Bartol-Puyal F, et al. Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study. Eye (Lond). 2024;38:3450\u20138.","journal-title":"Eye (Lond)"},{"key":"1269_CR38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/ceo.14054","volume":"50","author":"J Zarranz-Ventura","year":"2022","unstructured":"Zarranz-Ventura J, Parrado-Carrillo A, Nguyen V, et al. Creation of a neovascular age-related macular degeneration national database using a web-based platform: Fight Retinal Blindness Spain. Report 1: visual outcomes. Clin Exp Ophthalmol. 2022;50:312\u201324.","journal-title":"Clin Exp Ophthalmol"},{"key":"1269_CR39","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/s41433-025-03871-6","volume":"39","author":"J Zarranz-Ventura","year":"2025","unstructured":"Zarranz-Ventura J, Maria-P\u00e9rez S, Martin-Pinardel R, et al. Brolucizumab clinical and safety outcomes in a neovascular age-related macular degeneration national database: Fight Retinal Blindness Spain (FRB Spain). Eye (Lond). 2025;39:2407\u201314.","journal-title":"Eye (Lond)"},{"key":"1269_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/qhc.9.1.23","volume":"9","author":"G Johnston","year":"2000","unstructured":"Johnston G, Crombie I, Alder E, Davies H, Millard A. Reviewing audit: barriers and facilitating factors for effective clinical audit. Qual Health Care. 2000;9:23\u201336.","journal-title":"Qual Health Care"},{"key":"1269_CR41","doi-asserted-by":"crossref","unstructured":"Vahidi RG, Tabrizi JS, Iezadi S, Gholipour K, Mojahed F, Rasi A. Organizational facilitators and barriers to implementing effective clinical audit: systematic review. J Pioneer Med Sci. 2013;3:38\u201345.","DOI":"10.4103\/2249-4847.128726"},{"key":"1269_CR42","unstructured":"Jamtvedt G, Flottorp S, Ivers N. Audit and feedback as a quality strategy. In: Busse R, Klazing N, Pantelli D, et al., editors. Improving healthcare quality in Europe: characteristics, effectiveness and implementation of different strategies. 2019. Copenhagen: European Observatory on Health Systems and Policies. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK549284\/?report=printable. Accessed August 2025."}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-025-01269-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-025-01269-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T08:32:57Z","timestamp":1770453177000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-025-01269-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1007\/s40123-025-01269-x","relation":{},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors received honoraria from Roche, Basel, Switzerland while undertaking this study. Roche commissioned Triducive Partners Limited to facilitate the project and analyze the responses to the consensus statements in line with the Delphi methodology. The authors state the following conflicts of interest. Javier Zarranz-Ventura has worked with and received payment from AbbVie, Adverum, Alcon, Alimera Sciences, Bausch + Lomb, Bayer, Brill Pharma, DORC, Esteve, Novartis, Roche, Sandoz, Topcon, and Zeiss. Aude Ambresin has worked with and received payment from AbbVie, Apellis, Astellas, Bayer, Novartis, Optovue, RetinAI, and Roche. Andrew Chang has acted as a consultant and been on advisory boards for Roche, Bayer, Novartis, Alcon, Zeiss, Apellis, Astellas, and Opthea. Christiana Dinah has acted as a consultant and been on advisory boards for Roche, Boehringer Ingelheim, Bayer, AbbVie, Johnson & Johnson, Eyepoint Pharmaceuticals, Ocular Therapeutix, Alimera Sciences, Astellas, and Apellis; has had speaker fees from Roche, Boehringer Ingelheim, Bayer, Topcon Ltd, AbbVie, Apellis, and Astellas; and has had travel and conference support from Roche, Boehringer Ingelheim, and Apellis. Nancy M Holekamp is an employee of Roche, Basel, Switzerland; and has stock or stock options with Roche, Notal Vision, and Nacuity. Jorge Rocha has worked with and received payment from Apellis, Roche, Topcon, Astellas, and Ach\u00e9. Insaf Saffar is an employee of Roche, Basel, Switzerland. Rishi P Singh has had personal fees from Apellis, Iveric Bio, EyePoint, Regenxbio, Genentech, Bausch +Lomb, Zeiss, Alcon, and Regeneron; and has received research grants from Janssen.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Ethical approval was not required for this study, as it involved a non-interventional Delphi process with healthcare professionals only, and did not involve patients, vulnerable populations, or the collection of sensitive or personally identifiable data. In accordance with the Governance Arrangements for Research Ethics Committees (GAfREC), paragraph 2.3.3, research involving staff recruited by virtue of their professional role does not require NHS Research Ethics Committee review unless it involves access to confidential information or raises issues of professional performance. All respondents involved in the survey within the study were informed of the research purpose and that their data would remain anonymous. Their consent was assumed through the completion and submission of their survey responses.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}